Filing Details
- Accession Number:
- 0000950170-25-071591
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-14 17:05:11
- Reporting Period:
- 2025-05-12
- Filing Date:
- 2025-05-14
- Accepted Time:
- 2025-05-14 17:05:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1227636 | Neuronetics Inc. | STIM | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1783360 | Stephen Furlong | C/O Neuronetics, Inc. 3222 Phoenixville Pike Malvern PA 19355 | Evp, Cfo And Treasurer | No | No | No | No |
Transaction Summary
Sold: | 200,000 shares | Avg. Price: $4.27 | Total Value: $853,280.60 |
Number of Shares After Transactions: | 410,053 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-12 | 193,460 | $4.27 | 416,593 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-05-13 | 6,540 | $4.16 | 410,053 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.46 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.17 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.